Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014 - PubMed (original) (raw)
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014
Joseph F Hayes et al. Br J Psychiatry. 2017 Sep.
Abstract
BackgroundBipolar disorder and schizophrenia are associated with increased mortality relative to the general population. There is an international emphasis on decreasing this excess mortality.AimsTo determine whether the mortality gap between individuals with bipolar disorder and schizophrenia and the general population has decreased.MethodA nationally representative cohort study using primary care electronic health records from 2000 to 2014, comparing all patients diagnosed with bipolar disorder or schizophrenia and the general population. The primary outcome was all-cause mortality.ResultsIndividuals with bipolar disorder and schizophrenia had elevated mortality (adjusted hazard ratio (HR) = 1.79, 95% CI 1.67-1.88 and 2.08, 95% CI 1.98-2.19 respectively). Adjusted HRs for bipolar disorder increased by 0.14/year (95% CI 0.10-0.19) from 2006 to 2014. The adjusted HRs for schizophrenia increased gradually from 2004 to 2010 (0.11/year, 95% CI 0.04-0.17) and rapidly after 2010 (0.34/year, 95% CI 0.18-0.49).ConclusionsThe mortality gap between individuals with bipolar disorder and schizophrenia, and the general population is widening.
© The Royal College of Psychiatrists 2017.
Conflict of interest statement
Declaration of interestNone.
Figures
Fig. 1
All-cause mortality rate and adjusted hazard ratios compared with the general population. In bipolar disorder and schizophrenia (2000–2014). Mortality rates, per 100 person-years at-risk (PYAR) in (a) bipolar disorder and (b) schizophrenia groups. Adjusted hazard ratios (HRs) in (c) bipolar disorder and (d) schizophrenia groups.
Similar articles
- Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan.
Pan YJ, Yeh LL, Chan HY, Chang CK. Pan YJ, et al. Epidemiol Psychiatr Sci. 2020 Aug 14;29:e156. doi: 10.1017/S2045796020000694. Epidemiol Psychiatr Sci. 2020. PMID: 32792024 Free PMC article. - Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.
Pan YJ, Yeh LL, Chan HY, Chang CK. Pan YJ, et al. Psychol Med. 2017 Oct;47(14):2483-2493. doi: 10.1017/S0033291717001040. Epub 2017 Apr 26. Psychol Med. 2017. PMID: 28443526 - Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987-2010.
Ösby U, Westman J, Hällgren J, Gissler M. Ösby U, et al. Eur J Public Health. 2016 Oct;26(5):867-871. doi: 10.1093/eurpub/ckv245. Epub 2016 Jan 8. Eur J Public Health. 2016. PMID: 26748100 Free PMC article. - Excess mortality in bipolar disorders.
Miller C, Bauer MS. Miller C, et al. Curr Psychiatry Rep. 2014 Nov;16(11):499. doi: 10.1007/s11920-014-0499-z. Curr Psychiatry Rep. 2014. PMID: 25194314 Review. - Bipolar disorders.
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. McIntyre RS, et al. Lancet. 2020 Dec 5;396(10265):1841-1856. doi: 10.1016/S0140-6736(20)31544-0. Lancet. 2020. PMID: 33278937 Review.
Cited by
- Interventions for the management of obesity in people with bipolar disorder.
Tully A, Smyth S, Conway Y, Geddes J, Devane D, Kelly JP, Jordan F. Tully A, et al. Cochrane Database Syst Rev. 2020 Jul 20;7(7):CD013006. doi: 10.1002/14651858.CD013006.pub2. Cochrane Database Syst Rev. 2020. PMID: 32687629 Free PMC article. - Resting State Functional Connectivity Biomarkers of Treatment Response in Mood Disorders: A Review.
Taylor JJ, Kurt HG, Anand A. Taylor JJ, et al. Front Psychiatry. 2021 Mar 26;12:565136. doi: 10.3389/fpsyt.2021.565136. eCollection 2021. Front Psychiatry. 2021. PMID: 33841196 Free PMC article. Review. - National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health.
Waheed U, Stedman M, Davies M, Walther A, Solomon E, Ollier B, Heald AH. Waheed U, et al. Cardiovasc Endocrinol Metab. 2022 Sep 5;11(4):e0270. doi: 10.1097/XCE.0000000000000270. eCollection 2022 Dec. Cardiovasc Endocrinol Metab. 2022. PMID: 36092373 Free PMC article. No abstract available. - Severe mental illness diagnosis in English general hospitals 2006-2017: A registry linkage study.
Mansour H, Mueller C, Davis KAS, Burton A, Shetty H, Hotopf M, Osborn D, Stewart R, Sommerlad A. Mansour H, et al. PLoS Med. 2020 Sep 17;17(9):e1003306. doi: 10.1371/journal.pmed.1003306. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32941435 Free PMC article. - Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders.
Reponen EJ, Dieset I, Tesli M, Mørch RH, Aas M, Vedal TSJ, Haug E, Drange OK, Steen NE, Hope S, Szabo A, Gohar SM, Wedervang-Resell K, Djurovic S, Melle I, Aukrust P, Andreassen OA, Ueland T. Reponen EJ, et al. Front Psychiatry. 2020 Jul 10;11:672. doi: 10.3389/fpsyt.2020.00672. eCollection 2020. Front Psychiatry. 2020. PMID: 32754070 Free PMC article.
References
- Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011; 131: 101–4. - PubMed
- Hoang U, Goldacre MJ, Stewart R. Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr Scand 2013; 127: 195–201. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous